A Long-term Trial of OPC-34712 in Patients With Schizophrenia
Phase of Trial: Phase III
Latest Information Update: 26 Mar 2018
At a glance
- Drugs Brexpiprazole (Primary)
- Indications Schizophrenia
- Focus Adverse reactions
- Sponsors Otsuka Pharmaceutical
- 26 Mar 2018 Results published in the Psychiatry and Clinical Neurosciences
- 05 Oct 2016 Status changed from active, no longer recruiting to completed.
- 15 Sep 2015 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.